Watson Didn't Infringe Mucinex Patent: Fed. Circ.
By Erin Coe · July 7, 2011, 7:05 PM EDT
The Federal Circuit on Thursday affirmed that Watson Laboratories Inc.'s generic version of congestion reliever Mucinex did not infringe a Reckitt Benckiser Inc. patent....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login